6th Edition of Addiction World Conference 2027

Scientific Sessions - AWC 2027

Ketamine and Psychedelic-Assisted Therapies

Ketamine, psilocybin and other psychedelics are being tested for alcohol use disorder, depression and other conditions linked to addiction. This session reviews clinical evidence, safety, integration therapy and how ketamine-assisted treatment fits into wider care models.

Topics include: ketamine-assisted psychotherapy, psilocybin for alcohol use disorder, mechanisms of action, memory and cognition, safety and abuse liability, integrated treatment models.